Rhythm Pharmaceuticals, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 81.01%90.98%87.99%89.73%
EBT Margin -2,207.10%-766.22%-237.79%-200.00%
EBIT Margin -5,391.85%-757.92%-238.10%-204.04%
EBITDA Margin -5,391.85%-757.92%-238.10%-204.04%
Operating Margin -5,391.85%-757.92%-238.10%-204.04%
Net Margin -2,207.10%-766.22%-238.52%-203.32%
FCF Margin -4,642.90%-734.87%-175.91%-87.51%
Efficiency
Inventory Average 1.51M5.77M13.68M
Assets Average 82.04M205.97M284.37M356.00M357.61M362.51M
Equity Average 56.04M195.52M263.64M274.21M217.01M95.74M
Invested Capital -32.60M144.79M246.26M281.02M284.15M264.26M169.76M23.27M
Asset Utilization Ratio 0.070.220.36
Leverage & Solvency
Interest Coverage Ratio -34.45-13.27-12.89
Debt to Equity 0.000.000.635.05
Debt Ratio 0.010.000.320.28
Equity Ratio -2.650.950.950.910.860.690.510.06
Times Interest Earned -34.45-13.27-12.89
Valuation
Enterprise Value -10.76M644.57M875.02M715.69M206.49M1,307.25M2,440.49M3,119.34M
Market Capitalization 792.88M924.96M1,008.55M501.68M1,640.86M2,716.66M3,440.37M
Return Ratios
Return on Sales -22.07%-7.66%-2.39%-2.00%
Return on Capital Employed -0.43%-0.41%-0.56%-0.57%-0.61%-1.07%
Return on Assets -0.39%-0.36%-0.49%-0.51%-0.52%-0.72%
Return on Equity -0.57%-0.38%-0.53%-0.66%-0.85%-2.72%